🔗 Visit the ClinicalTrials.gov page for NCT00683241
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Trial watch: Dendritic cell-based interventions for cancer therapy. | Oncoimmunology | 2012 | 1.51 |
| 2 | Trial watch: Dendritic cell-based interventions for cancer therapy. | Oncoimmunology | 2013 | 1.09 |
| 3 | Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies. | Cancer Manag Res | 2010 | 1.08 |
| 4 | Immunotherapy in ovarian cancer. | Hum Vaccin Immunother | 2012 | 0.99 |
| 5 | Trial watch: Dendritic cell-based anticancer therapy. | Oncoimmunology | 2014 | 0.90 |
| 6 | Optimizing dendritic cell-based approaches for cancer immunotherapy. | Yale J Biol Med | 2014 | 0.85 |
| 7 | Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy. | Front Immunol | 2015 | 0.82 |
| 8 | Targeting CD8+ T-cell tolerance for cancer immunotherapy. | Immunotherapy | 2014 | 0.81 |